S
77.39
1.73 (2.29%)
| Penutupan Terdahulu | 75.66 |
| Buka | 75.62 |
| Jumlah Dagangan | 767,523 |
| Purata Dagangan (3B) | 1,316,269 |
| Modal Pasaran | 3,899,983,872 |
| Harga / Buku (P/B) | 17.17 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2025 - 11 Aug 2025 |
| EPS Cair (TTM) | -4.74 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 22.73% |
| Nisbah Semasa (MRQ) | 19.64 |
| Aliran Tunai Operasi (OCF TTM) | -89.32 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -33.98 M |
| Pulangan Atas Aset (ROA TTM) | -52.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -105.54% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Soleno Therapeutics, Inc. | Menurun | Menaik |
AISkor Stockmoo
0.9
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.88 |
|
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.89% |
| % Dimiliki oleh Institusi | 111.99% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 145.00 (Piper Sandler, 87.36%) | Beli |
| Median | 105.00 (35.68%) | |
| Rendah | 97.00 (Guggenheim, 25.34%) | Beli |
| Purata | 111.86 (44.54%) | |
| Jumlah | 7 Beli | |
| Harga Purata @ Panggilan | 71.97 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Baird | 08 May 2025 | 105.00 (35.68%) | Beli | 76.26 |
| 27 Mar 2025 | 102.00 (31.80%) | Beli | 67.39 | |
| Guggenheim | 08 May 2025 | 97.00 (25.34%) | Beli | 76.26 |
| 28 Mar 2025 | 81.00 (4.66%) | Beli | 71.99 | |
| Piper Sandler | 24 Apr 2025 | 145.00 (87.36%) | Beli | 74.23 |
| HC Wainwright & Co. | 15 Apr 2025 | 100.00 (29.22%) | Beli | 70.25 |
| 31 Mar 2025 | 100.00 (29.22%) | Beli | 71.45 | |
| Stifel | 28 Mar 2025 | 108.00 (39.55%) | Beli | 71.99 |
| Cantor Fitzgerald | 27 Mar 2025 | 123.00 (58.94%) | Beli | 67.39 |
| Laidlaw & Co. | 27 Mar 2025 | 105.00 (35.68%) | Beli | 67.39 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |